rs924843423
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_005257.6(GATA6):āc.172A>Gā(p.Ser58Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000974 in 1,437,034 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_005257.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GATA6 | NM_005257.6 | c.172A>G | p.Ser58Gly | missense_variant | 2/7 | ENST00000269216.10 | NP_005248.2 | |
GATA6 | XM_047437483.1 | c.172A>G | p.Ser58Gly | missense_variant | 2/7 | XP_047293439.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GATA6 | ENST00000269216.10 | c.172A>G | p.Ser58Gly | missense_variant | 2/7 | 1 | NM_005257.6 | ENSP00000269216.3 | ||
GATA6 | ENST00000581694.1 | c.172A>G | p.Ser58Gly | missense_variant | 1/6 | 1 | ENSP00000462313.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000462 AC: 1AN: 216346Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 120480
GnomAD4 exome AF: 0.00000974 AC: 14AN: 1437034Hom.: 0 Cov.: 31 AF XY: 0.00000560 AC XY: 4AN XY: 714050
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Monogenic diabetes Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Personalized Diabetes Medicine Program, University of Maryland School of Medicine | Aug 01, 2017 | ACMG Criteria:PP3 (4 predictors), BP4 (7 predictors), PM2 (absent in database) - |
Pancreatic hypoplasia-diabetes-congenital heart disease syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic | - | Potent mutations in GATA6 gene are associated with neonatal diabetes, decreased insulin production due to pancreatic aplasia or hypoplasia. Also associated with isolated cardiac abnormalities in children, like atrial septal defects.However no sufficient evidence is found to ascertain the role of this particular variant rs924843423 yet. - |
Atrioventricular septal defect 5 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 25, 2020 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The glycine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with GATA6-related conditions. ClinVar contains an entry for this variant (Variation ID: 549549). This variant is not present in population databases (ExAC no frequency). This sequence change replaces serine with glycine at codon 58 of the GATA6 protein (p.Ser58Gly). The serine residue is weakly conserved and there is a small physicochemical difference between serine and glycine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at